IBIS Technologies

📍 Enschede, Netherlands🗓 Founded 1996👥 6 employees💰 Last funded 1999
IBIS Technologies is a leader in innovative label-free analytical systems for profiling biomolecular interactions using Surface Plasmon Resonance imaging (SPRi) technology. SPR is the recognized golden standard for obtaining accurate kinetic data. Because of its multiplex format and the back-and-forth flow technology for ligand deposition and sample injection, the IBIS MX96 analyses 96 (bio)molecular interactions simultaneously using very low sample volume. Saving your research department time, labor, sensors and sample. By injecting 96 analytes in series using the MX96's autosampler, almost 10,000 sensorgrams are obtained in an overnight run. Months of work can be saved and the time consuming screening for epitope discovery can be speed up dramatically. Especially for the applications as epitope discovery, affinity ranking and cell interaction studies, the IBIS MX96 has proven its success at large pharmaceutical companies, biotech companies and universities.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
1996
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in IBIS Technologies?
IBIS Technologies has 1 investor on record on gritt.io, 1 mid-stage.
When did IBIS Technologies last raise funding?
The most recent investment in IBIS Technologies recorded on gritt.io was in 1999.
When was IBIS Technologies founded?
IBIS Technologies was founded in 1996.
What industry is IBIS Technologies in?
IBIS Technologies operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is IBIS Technologies based?
IBIS Technologies is headquartered in Enschede, Netherlands.